NSPR vs PATH
InspireMD Inc (NSPR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
InspireMD Inc (NSPR) is a medical devices company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported NSPR revenue for 2024-12-31 was $7.0M. Net income was -$32.0M. Revenue was up 13.0% from 2023-12-31 to 2024-12-31. NSPR currently screens at market cap $34.6M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
NSPR currently screens at market cap $34.6M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the NSPR and PATH stock pages for the full models.
Not investment advice.